| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |